Miriam Kull

Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Functional and molecular analyses reveal impaired HSPCs in Multiple Myeloma patients post-induction.

Functional and molecular analyses reveal impaired HSPCs in Multiple Myeloma patients post-induction.

Journal: Stem cells translational medicine

Published: August 29, 2025

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.

Journal: Bone marrow transplantation

Published: October 04, 2024

A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

Journal: HemaSphere

Published: October 01, 2024

Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma.

Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma.

Journal: Vaccines

Published: September 24, 2024

Real-world analysis of teclistamab in 123 RRMM patients from Germany.

Real-world analysis of teclistamab in 123 RRMM patients from Germany.

Journal: Leukemia

Published: November 10, 2023

CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma.

CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma.

Journal: HemaSphere

Published: June 04, 2023

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.

Journal: Nature cancer

Published: December 21, 2022

Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).

Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: April 12, 2022

Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.

Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.

Journal: Nature communications

Published: January 22, 2021

Cereblon enhancer methylation and IMiD resistance in multiple myeloma.

Cereblon enhancer methylation and IMiD resistance in multiple myeloma.

Journal: Blood

Published: December 17, 2020

Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma.

Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma.

Journal: Blood advances

Published: October 05, 2020

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.

Journal: Haematologica

Published: July 30, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026